Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 72

Sort by

Sort Order Select

Journal Articles

APR-246 Combined with Azacitidine (AZA) in TP53 Mutated Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML). a Phase 2 Study By the Groupe Francophone Des Myélodysplasies (GFM)

Blood (2019) 134 (Supplement_1): 677.

https://doi.org/10.1182/blood-2019-125579

Published: 2019

Journal Articles

Recipient Signaling through the Cannabinoid Type 2 Receptor Regulates IL-6 Independent Neuroinflammation during Graft Versus Host Disease

Alison Moe, PhD, Garrett Sauber, BS, Vivian Zhou, PhD, Anissa Lapitz, BS, Cecilia Hillard, PhD, William R. Drobyski, MD

Blood (2019) 134 (Supplement_1): 195.

https://doi.org/10.1182/blood-2019-122746

Published: 2019

Journal Articles

Aspacytarabine (BST-236) Is Safe and Efficacious As a Single-Agent, First-Line Therapy for Patients with Acute Myeloid Leukemia Unfit for Standard Chemotherapy. Integrated Results from a Phase 1/2a and an Ongoing Phase 2b

Jessica K. Altman, Tsila Zuckerman, MD, Olga Frankfurt, MD, Selina M. Luger, MD FRCPC, Dale L. Bixby, MD, Vamsi Kota, MBBS, Micah M. Burch, Ofir Wolach, Itai Levi, MD, Anna Gourevitch, Ron Ram, MD, Liat Flaishon, Shoshi Tessler, Stela Gengrinovitch, Ruth Ben Yakar, Jacob M. Rowe, MB, BS

Blood (2019) 134 (Supplement_1): 179.

https://doi.org/10.1182/blood-2019-124330

Published: 2019

Journal Articles

A Case of Mistaken Identity: TTP-like State Due to Heroin Overdose

Phani Borra, MD, Cory Edward Mellon, MD

Blood (2019) 134 (Supplement_1): 4905.

https://doi.org/10.1182/blood-2019-128537

Published: 2019

Journal Articles

Early Intracranial Hemorrhages in Acute Promyelocytic Leukemia: Analysis of Neuroradiological and Clinico-Biological Parameters

Carmelo Gurnari, MD, Francesca Di Giuliano, Mariadomenica Divona, Alfonso Piciocchi, Laura Cicconi, Adriano Venditti, Maria Ilaria Del Principe, William Arcese, Francesco Lo-Coco, Francesco Garaci, MD, Maria Teresa Voso, MD

Blood (2019) 134 (Supplement_1): 5170.

https://doi.org/10.1182/blood-2019-125058

Published: 2019

Journal Articles

Thirty-Day Transfusion and G-CSF Requirement after CD19 CAR T Infusion

Jingmei Hsu, MD, Usama Gergis, MD MBA, Tsiporah B. Shore, MD, Sebastian Mayer, MD, Adrienne A. Phillips, MD MPH, Danielle Guarneri, BS, CCRP, Maria Baldo, PA, Ljiljana V. Vasovic, MD, Yen-Michael S. Hsu, MD PhD, Robert Andrew Desimone, MD, Melissa M. Cushing, MD, Koen Van Besien, MD PhD

Blood (2019) 134 (Supplement_1): 1169.

https://doi.org/10.1182/blood-2019-131306

Published: 2019

Journal Articles

Calpain-1 Contributes to Pain and Organ Damage in Sickle Cell Disease

Stacy B Kiven, BS, Jianxun Lei, PhD, Varun Sagi, BS, Huy Tran, BS, Ying Wang, PhD, Piyusha P Pagare, PhD, Jennifer O Nwankwo, PhD, Nils Lambrecht, MD PhD, Kalpna Gupta, PhD

Blood (2019) 134 (Supplement_1): 76.

https://doi.org/10.1182/blood-2019-127761

Published: 2019

Journal Articles

Increased Cortical Glycolysis Following CD19 CART Therapy: A Radiographic Surrogate for an Altered Blood-Brain Barrier

Ali Bukhari, MD, Vivek Kesari, MD, Reza Sirous, MD, Noa G. Holtzman, MD, Seung Tae Lee, MD PhD, Natalie Gahres, RN, Elizabeth Hutnick, RN, Kathleen Ruehle, RN, Mehmet Hakan Kocoglu, MD, Ashraf Z. Badros, Jean A. Yared, MD, Nancy M. Hardy, MD, Aaron P. Rapoport, Babak Saboury, MD MPH, Saurabh Dahiya, MD

Blood (2019) 134 (Supplement_1): 4454.

https://doi.org/10.1182/blood-2019-125794

Published: 2019

Journal Articles

Characterization of Congenital Sideroblastic Anemia Model Due to ABCB7 Defects: How Do Defects in Iron-Sulfur Cluster Metabolism Lead to Ring Sideroblast Formation?

Tohru Fujiwara, MD PhD, Chie Suzuki, Tetsuro Ochi, Koya Ono, MD, Kei Saito, Noriko Fukuhara, MD PhD, Yasushi Onishi, MD PhD, Hisayuki Yokoyama, MD PhD, Shinichi Fujimaki, Yukio Nakamura, MD PhD, Hideo Harigae, MD PhD

Blood (2019) 134 (Supplement_1): 2232.

https://doi.org/10.1182/blood-2019-123918

Published: 2019

Journal Articles

Feasibility of Outpatient High Dose Cytarabine in Patients with Acute Myeloid Leukemia

Chin-Hin NG, MD MRCP, FRCPATH, MCI, Xiaojuan Chen, BsN, MsN, Foong-Gwan Lee, BsN, Shi Hui Clarice Choong, MBBS, MRCP, Xiao-Shi Saw, BSc(Pharm), Lon-Wann Sai, MBBS, MRCP, Michelle Poon, MBBS, MRCP, FRCPATH, Hian Li Esther Hian Li Chan, MBBS, MRCP, FRCPATH, Melissa Ooi, MB BCh, BAO, MRCP(I), FRCPath, PhD, Yen Lin Chee, MBBS, FRCPATH, PhD, Yee Mei Lee, BsN, MsN, PhD

Blood (2019) 134 (Supplement_1): 2152.

https://doi.org/10.1182/blood-2019-129858

Published: 2019

Journal Articles

Neurological Adverse Events Following CAR-T Cell Therapy: A Real-World Analysis of Adult Patients Treated with Axicabtagene Ciloleucel or Tisagenlecleucel

Ajeet Gajra, MD FACP, Marjorie E Zettler, PhD MPH, Eli G Phillips Jr., PharmD, JD, Andrew J Klink, PhD MPH, Jonathan K. Kish, PhD MPH, Sonam Mehta, Bruce Feinberg, DO

Blood (2019) 134 (Supplement_1): 1952.

https://doi.org/10.1182/blood-2019-129593

Published: 2019

Journal Articles

Exploring Anemia's Impact on Brain Microstructure, Volume, Functional Connectivity, Iron and Cognitive Performance

Soyoung Choi, BA, Sharon H O'Neil, Anand A Joshi, PhD, Xin Miao, PhD, Jian Li, PhD, Justin P Haldar, PhD, Thomas Coates, MD, Richard M Leahy, PhD, John C Wood, MD PhD

Blood (2019) 134 (Supplement_1): 3553.

https://doi.org/10.1182/blood-2019-129544

Published: 2019

Journal Articles

ANTI-PD-1 Treatment in a Family with Constitutional Mismatch Repair Deficiency Syndrome with Multiple Cancers from Turkey. Is Cancer Immunoprevention with Checkpoint Inhibitors HAS a Role in CASES with Homozygous Mutationis

Emel Unal, Derya Ozyoruk, Nurdan Tacyildiz, Ferda Pi̇narli̇, A Erdogan, S Hanalioglu, Arzu Erdem, Meral Beksac, MD

Blood (2019) 134 (Supplement_1): 5632.

https://doi.org/10.1182/blood-2019-130102

Published: 2019

Journal Articles

Increased Cerebral Metabolic Stress Is Associated with Diminished Functional Connectivity in Pediatric Sickle Cell Anemia

Melanie E Fields, MD MSCI, Amy Mirro, MEng, Kristin P Guilliams, MD MSCI, Michael M Binkley, MS, Cihat Eldeniz, PhD, Slim Fellah, PhD, Andria L Ford, MD MSCI, Yasheng Chen, DSc, Allison A. King, MD MPH, PhD, Hongyu An, DSc, Christopher Smyser, MD, Jin-Moo Lee, MD PhD

Blood (2019) 134 (Supplement_1): 989.

https://doi.org/10.1182/blood-2019-125158

Published: 2019

Journal Articles

Thrombopoietin Has Protective Effect in Neonatal Hypoxia-Ischemia Rat Model

Liang Li, PhD, Liuming Yang, Hongwu Xin, Beng H Chong, MBBS, PhD, Mo Yang, MD

Blood (2019) 134 (Supplement_1): 4898.

https://doi.org/10.1182/blood-2019-131575

Published: 2019

Journal Articles

Non-Diffuse Large B-Cell Primary Central Nervous System Lymphoma

Sangeetha Gandhi, MBBS, Grzegorz S. Nowakowski, MD, Thomas M. Habermann, MD, Kay M. Ristow, BS, Patrick Johnston

Blood (2018) 132 (Supplement 1): 4208.

https://doi.org/10.1182/blood-2018-99-119741

Published: 2018

Journal Articles

High-Dose Intravenous Immunoglobulin and Immunosuppressive Therapy Have Therapeutic Potential for Non-Infectious Myelopathy and Peripheral Neuropathy Following Cord Blood Transplantation

Michiho Ebihara, MD, Shinsuke Takagi, Yoshikazu Uesaka, MD PhD, Takashi Mitsuki, MD, Mitsuhiro Yuasa, MD, Kosei Kageyama, MD, Daisuke Kaji, MD, Yuki Taya, MD PhD, Aya Nishida, MD, Kazuya Ishiwata, MD, Hisashi Yamamoto, MD, Go Yamamoto, MD PhD, Yuki Asano-Mori, MD PhD, Yukako Koike, MD PhD, Shigeyoshi Makino, MD PhD, Akiko Yoneyama, MD PhD, Atsushi Wake, MD PhD, Naoyuki Uchida, MD PhD, Shuichi Taniguchi, MD PhD

Blood (2018) 132 (Supplement 1): 3390.

https://doi.org/10.1182/blood-2018-99-116308

Published: 2018

Journal Articles

Allogenic C57B/6->B6D2F1 Transplantation As a Model for Graft Versus Host Disease in the Brain

Sarah Bryant, BS, Ian Moore, PhD, Bianca Nagata, Danielle Springer, VMD, DACLAM, Audrey Noguchi, Morteza Peiravi, Karlie Sharma, PhD, Sherry M. Koontz, Harry Malech, MD, Elizabeth Kang, MD

Blood (2017) 130 (Supplement 1): 3172.

https://doi.org/10.1182/blood.V130.Suppl_1.3172.3172

Published: 2017

Journal Articles

Absence of T1 Hyperintensity in the Brain of Thalassemia Patients after Multiple Administrations of Gadobutrol

Antonella Meloni, PhD, Domenico Montanaro, Daniele De Marchi, Maria Chiara Resta, Petra Keilberg, Laura Pistoia, MD, Anna Spasiano, Tommaso Casini, Caterina Cinzia De Bari, Sara De Cori, Vincenzo Positano, Paolo Di Bartolomeo, MD, Alessia Pepe, MD

Blood (2017) 130 (Supplement 1): 4767.

https://doi.org/10.1182/blood.V130.Suppl_1.4767.4767

Published: 2017

Journal Articles

BST-236, a Novel Cytarabine Pro-Drug, Enables Safe and Effective Administration of High Dose Cytarabine to Older or Unfit Patients with Acute Leukemia. Results of a Phase I/II Study

Tsila Zuckerman, MD, Ron Ram, MD, Maya Koren-Michowitz, MD, Luiza Akria, MD, Ron Hoffman, Israel Henig, MD, Yishai Ofran, MD, Noa Lavi, MD, Netanel A Horowitz, MD, Olga Nudelman, MD, Shay Yeganeh, MD, Stela Gengrinovitch, PhD, Liat Flaishon, PhD MD, Ruth Ben Yakar, PhD, Jacob M. Rowe, MD

Blood (2017) 130 (Supplement 1): 893.

https://doi.org/10.1182/blood.V130.Suppl_1.893.893

Published: 2017

NARROW

APR-246 Combined with Azacitidine (AZA) in TP53 Mutated Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML). a Phase 2 Study By the Groupe Francophone Des Myélodysplasies (GFM)

Recipient Signaling through the Cannabinoid Type 2 Receptor Regulates IL-6 Independent Neuroinflammation during Graft Versus Host Disease

Aspacytarabine (BST-236) Is Safe and Efficacious As a Single-Agent, First-Line Therapy for Patients with Acute Myeloid Leukemia Unfit for Standard Chemotherapy. Integrated Results from a Phase 1/2a and an Ongoing Phase 2b

A Case of Mistaken Identity: TTP-like State Due to Heroin Overdose

Early Intracranial Hemorrhages in Acute Promyelocytic Leukemia: Analysis of Neuroradiological and Clinico-Biological Parameters

Thirty-Day Transfusion and G-CSF Requirement after CD19 CAR T Infusion

Calpain-1 Contributes to Pain and Organ Damage in Sickle Cell Disease

Increased Cortical Glycolysis Following CD19 CART Therapy: A Radiographic Surrogate for an Altered Blood-Brain Barrier

Characterization of Congenital Sideroblastic Anemia Model Due to ABCB7 Defects: How Do Defects in Iron-Sulfur Cluster Metabolism Lead to Ring Sideroblast Formation?

Feasibility of Outpatient High Dose Cytarabine in Patients with Acute Myeloid Leukemia

Neurological Adverse Events Following CAR-T Cell Therapy: A Real-World Analysis of Adult Patients Treated with Axicabtagene Ciloleucel or Tisagenlecleucel

Exploring Anemia's Impact on Brain Microstructure, Volume, Functional Connectivity, Iron and Cognitive Performance

ANTI-PD-1 Treatment in a Family with Constitutional Mismatch Repair Deficiency Syndrome with Multiple Cancers from Turkey. Is Cancer Immunoprevention with Checkpoint Inhibitors HAS a Role in CASES with Homozygous Mutationis

Increased Cerebral Metabolic Stress Is Associated with Diminished Functional Connectivity in Pediatric Sickle Cell Anemia

Thrombopoietin Has Protective Effect in Neonatal Hypoxia-Ischemia Rat Model

Non-Diffuse Large B-Cell Primary Central Nervous System Lymphoma

High-Dose Intravenous Immunoglobulin and Immunosuppressive Therapy Have Therapeutic Potential for Non-Infectious Myelopathy and Peripheral Neuropathy Following Cord Blood Transplantation

Allogenic C57B/6->B6D2F1 Transplantation As a Model for Graft Versus Host Disease in the Brain

Absence of T1 Hyperintensity in the Brain of Thalassemia Patients after Multiple Administrations of Gadobutrol

BST-236, a Novel Cytarabine Pro-Drug, Enables Safe and Effective Administration of High Dose Cytarabine to Older or Unfit Patients with Acute Leukemia. Results of a Phase I/II Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only